Eva Quesada-Lopez
Terrassa, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Prediction of preterm pre-eclampsia and preterm small-for-gestational-age at 24-28 weeks of gestation using ultrasound and biochemical markers in high-risk pregnancies treated with aspirin: A secondary analysis of the StopPRE trial.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: June 10, 2026
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: March 11, 2025
Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study.
Journal: Cardiovascular diabetology
Published: January 09, 2025
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.
Journal: Nature medicine
Published: July 23, 2024
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: May 10, 2024
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factor.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: July 02, 2023
Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trial.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: April 28, 2023
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial.
Journal: JAMA
Published: February 22, 2023
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial.
Journal: JMIR research protocols
Published: February 22, 2022
Shared risk factors for COVID-19 and preeclampsia in the first trimester: An observational study.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: February 17, 2022
Impact of thyroid universal screening on pregnancy outcomes in real-world clinical practice.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: January 12, 2022
Implementation of routine first-trimester combined screening for preeclampsia based on the Gaussian algorithm: A clinical effectiveness study.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: December 11, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026